Review



mfei hf  (New England Biolabs)


Bioz Verified Symbol New England Biolabs is a verified supplier
Bioz Manufacturer Symbol New England Biolabs manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 94
      Buy from Supplier

    Structured Review

    New England Biolabs mfei hf
    Rational design and the experimental validation of the LIS-seq workflow (A) Schematic representation of the experimental strategy of the establishment of single provirus-integrated cellular clones (sinpro clones). A total of 14 clones, in which proviruses demonstrated different transcriptional phenotypes were assigned to four different groups, including the active group (the A group, 4 clones), the attenuated active group (the A-group, 6 clones), the silent group (the S group, 3 clones) and the fluctuation group (the F group, 1 clone) and applied to LIS-seq for the identification of HIV integration sites. (B) Schematic representation of the experimental workflow of LIS-seq. Genomic DNA isolated from sinpro clones was digested with restriction enzymes, HpyCH4III and BplI, followed by in vitro transcription, and RT-PCR amplification with primers embedded with Illumina adaptor sequences. Amplicons are sequenced as 50 bp single reads on a NovaSeq 6000 sequencer (Illumina). (C) Verification of restriction enzyme digestion of genomic DNA isolated from sinpro clones. Genomic DNA is either subjected to BplI plus HpyCH4III (lane 1) or BplI plus HpyCH4III as well <t>as</t> <t>MfeI-HF</t> plus Hpy166I (lane 2). Of note, genomic DNA is digested independently by both pairs of restriction enzymes shown in lane 2. (D) Verification of the production of single-stranded RNA (ssRNA) resulting from in vitro transcription. ssRNA was used as the template for the performance of RT-PCR amplification, yielding a correct 220 bp product. (E) Expected result from the sequencing amplicon using LIS-seq. 2.0% (wt/vol) agarose gel displaying a faint PCR smear corresponding to fragments of different lengths harboring the integration site of the provirus in 14 sinpro clones. (F) Expected result from the sequencing amplicon in a pool of infected cells using LIS-seq. 2.0% (wt/vol) agarose gel displaying a faint PCR smear corresponding to fragments of different lengths harboring the integration site of the provirus.
    Mfei Hf, supplied by New England Biolabs, used in various techniques. Bioz Stars score: 94/100, based on 112 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/mfei hf/product/New England Biolabs
    Average 94 stars, based on 112 article reviews
    mfei hf - by Bioz Stars, 2026-02
    94/100 stars

    Images

    1) Product Images from "An in vitro transcription-based protocol for mapping HIV integration sites using lentiviral integration site sequencing"

    Article Title: An in vitro transcription-based protocol for mapping HIV integration sites using lentiviral integration site sequencing

    Journal: STAR Protocols

    doi: 10.1016/j.xpro.2025.104284

    Rational design and the experimental validation of the LIS-seq workflow (A) Schematic representation of the experimental strategy of the establishment of single provirus-integrated cellular clones (sinpro clones). A total of 14 clones, in which proviruses demonstrated different transcriptional phenotypes were assigned to four different groups, including the active group (the A group, 4 clones), the attenuated active group (the A-group, 6 clones), the silent group (the S group, 3 clones) and the fluctuation group (the F group, 1 clone) and applied to LIS-seq for the identification of HIV integration sites. (B) Schematic representation of the experimental workflow of LIS-seq. Genomic DNA isolated from sinpro clones was digested with restriction enzymes, HpyCH4III and BplI, followed by in vitro transcription, and RT-PCR amplification with primers embedded with Illumina adaptor sequences. Amplicons are sequenced as 50 bp single reads on a NovaSeq 6000 sequencer (Illumina). (C) Verification of restriction enzyme digestion of genomic DNA isolated from sinpro clones. Genomic DNA is either subjected to BplI plus HpyCH4III (lane 1) or BplI plus HpyCH4III as well as MfeI-HF plus Hpy166I (lane 2). Of note, genomic DNA is digested independently by both pairs of restriction enzymes shown in lane 2. (D) Verification of the production of single-stranded RNA (ssRNA) resulting from in vitro transcription. ssRNA was used as the template for the performance of RT-PCR amplification, yielding a correct 220 bp product. (E) Expected result from the sequencing amplicon using LIS-seq. 2.0% (wt/vol) agarose gel displaying a faint PCR smear corresponding to fragments of different lengths harboring the integration site of the provirus in 14 sinpro clones. (F) Expected result from the sequencing amplicon in a pool of infected cells using LIS-seq. 2.0% (wt/vol) agarose gel displaying a faint PCR smear corresponding to fragments of different lengths harboring the integration site of the provirus.
    Figure Legend Snippet: Rational design and the experimental validation of the LIS-seq workflow (A) Schematic representation of the experimental strategy of the establishment of single provirus-integrated cellular clones (sinpro clones). A total of 14 clones, in which proviruses demonstrated different transcriptional phenotypes were assigned to four different groups, including the active group (the A group, 4 clones), the attenuated active group (the A-group, 6 clones), the silent group (the S group, 3 clones) and the fluctuation group (the F group, 1 clone) and applied to LIS-seq for the identification of HIV integration sites. (B) Schematic representation of the experimental workflow of LIS-seq. Genomic DNA isolated from sinpro clones was digested with restriction enzymes, HpyCH4III and BplI, followed by in vitro transcription, and RT-PCR amplification with primers embedded with Illumina adaptor sequences. Amplicons are sequenced as 50 bp single reads on a NovaSeq 6000 sequencer (Illumina). (C) Verification of restriction enzyme digestion of genomic DNA isolated from sinpro clones. Genomic DNA is either subjected to BplI plus HpyCH4III (lane 1) or BplI plus HpyCH4III as well as MfeI-HF plus Hpy166I (lane 2). Of note, genomic DNA is digested independently by both pairs of restriction enzymes shown in lane 2. (D) Verification of the production of single-stranded RNA (ssRNA) resulting from in vitro transcription. ssRNA was used as the template for the performance of RT-PCR amplification, yielding a correct 220 bp product. (E) Expected result from the sequencing amplicon using LIS-seq. 2.0% (wt/vol) agarose gel displaying a faint PCR smear corresponding to fragments of different lengths harboring the integration site of the provirus in 14 sinpro clones. (F) Expected result from the sequencing amplicon in a pool of infected cells using LIS-seq. 2.0% (wt/vol) agarose gel displaying a faint PCR smear corresponding to fragments of different lengths harboring the integration site of the provirus.

    Techniques Used: Biomarker Discovery, Clone Assay, Isolation, In Vitro, Reverse Transcription Polymerase Chain Reaction, Amplification, Sequencing, Agarose Gel Electrophoresis, Infection



    Similar Products

    mfei hf  (New England Biolabs)
    94
    New England Biolabs mfei hf
    Rational design and the experimental validation of the LIS-seq workflow (A) Schematic representation of the experimental strategy of the establishment of single provirus-integrated cellular clones (sinpro clones). A total of 14 clones, in which proviruses demonstrated different transcriptional phenotypes were assigned to four different groups, including the active group (the A group, 4 clones), the attenuated active group (the A-group, 6 clones), the silent group (the S group, 3 clones) and the fluctuation group (the F group, 1 clone) and applied to LIS-seq for the identification of HIV integration sites. (B) Schematic representation of the experimental workflow of LIS-seq. Genomic DNA isolated from sinpro clones was digested with restriction enzymes, HpyCH4III and BplI, followed by in vitro transcription, and RT-PCR amplification with primers embedded with Illumina adaptor sequences. Amplicons are sequenced as 50 bp single reads on a NovaSeq 6000 sequencer (Illumina). (C) Verification of restriction enzyme digestion of genomic DNA isolated from sinpro clones. Genomic DNA is either subjected to BplI plus HpyCH4III (lane 1) or BplI plus HpyCH4III as well <t>as</t> <t>MfeI-HF</t> plus Hpy166I (lane 2). Of note, genomic DNA is digested independently by both pairs of restriction enzymes shown in lane 2. (D) Verification of the production of single-stranded RNA (ssRNA) resulting from in vitro transcription. ssRNA was used as the template for the performance of RT-PCR amplification, yielding a correct 220 bp product. (E) Expected result from the sequencing amplicon using LIS-seq. 2.0% (wt/vol) agarose gel displaying a faint PCR smear corresponding to fragments of different lengths harboring the integration site of the provirus in 14 sinpro clones. (F) Expected result from the sequencing amplicon in a pool of infected cells using LIS-seq. 2.0% (wt/vol) agarose gel displaying a faint PCR smear corresponding to fragments of different lengths harboring the integration site of the provirus.
    Mfei Hf, supplied by New England Biolabs, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/mfei hf/product/New England Biolabs
    Average 94 stars, based on 1 article reviews
    mfei hf - by Bioz Stars, 2026-02
    94/100 stars
    		  Buy from Supplier
    r3589s  (New England Biolabs)
    94
    New England Biolabs r3589s
    Rational design and the experimental validation of the LIS-seq workflow (A) Schematic representation of the experimental strategy of the establishment of single provirus-integrated cellular clones (sinpro clones). A total of 14 clones, in which proviruses demonstrated different transcriptional phenotypes were assigned to four different groups, including the active group (the A group, 4 clones), the attenuated active group (the A-group, 6 clones), the silent group (the S group, 3 clones) and the fluctuation group (the F group, 1 clone) and applied to LIS-seq for the identification of HIV integration sites. (B) Schematic representation of the experimental workflow of LIS-seq. Genomic DNA isolated from sinpro clones was digested with restriction enzymes, HpyCH4III and BplI, followed by in vitro transcription, and RT-PCR amplification with primers embedded with Illumina adaptor sequences. Amplicons are sequenced as 50 bp single reads on a NovaSeq 6000 sequencer (Illumina). (C) Verification of restriction enzyme digestion of genomic DNA isolated from sinpro clones. Genomic DNA is either subjected to BplI plus HpyCH4III (lane 1) or BplI plus HpyCH4III as well <t>as</t> <t>MfeI-HF</t> plus Hpy166I (lane 2). Of note, genomic DNA is digested independently by both pairs of restriction enzymes shown in lane 2. (D) Verification of the production of single-stranded RNA (ssRNA) resulting from in vitro transcription. ssRNA was used as the template for the performance of RT-PCR amplification, yielding a correct 220 bp product. (E) Expected result from the sequencing amplicon using LIS-seq. 2.0% (wt/vol) agarose gel displaying a faint PCR smear corresponding to fragments of different lengths harboring the integration site of the provirus in 14 sinpro clones. (F) Expected result from the sequencing amplicon in a pool of infected cells using LIS-seq. 2.0% (wt/vol) agarose gel displaying a faint PCR smear corresponding to fragments of different lengths harboring the integration site of the provirus.
    R3589s, supplied by New England Biolabs, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/r3589s/product/New England Biolabs
    Average 94 stars, based on 1 article reviews
    r3589s - by Bioz Stars, 2026-02
    94/100 stars
    		  Buy from Supplier
    r3589v  (New England Biolabs)
    94
    New England Biolabs r3589v
    Rational design and the experimental validation of the LIS-seq workflow (A) Schematic representation of the experimental strategy of the establishment of single provirus-integrated cellular clones (sinpro clones). A total of 14 clones, in which proviruses demonstrated different transcriptional phenotypes were assigned to four different groups, including the active group (the A group, 4 clones), the attenuated active group (the A-group, 6 clones), the silent group (the S group, 3 clones) and the fluctuation group (the F group, 1 clone) and applied to LIS-seq for the identification of HIV integration sites. (B) Schematic representation of the experimental workflow of LIS-seq. Genomic DNA isolated from sinpro clones was digested with restriction enzymes, HpyCH4III and BplI, followed by in vitro transcription, and RT-PCR amplification with primers embedded with Illumina adaptor sequences. Amplicons are sequenced as 50 bp single reads on a NovaSeq 6000 sequencer (Illumina). (C) Verification of restriction enzyme digestion of genomic DNA isolated from sinpro clones. Genomic DNA is either subjected to BplI plus HpyCH4III (lane 1) or BplI plus HpyCH4III as well <t>as</t> <t>MfeI-HF</t> plus Hpy166I (lane 2). Of note, genomic DNA is digested independently by both pairs of restriction enzymes shown in lane 2. (D) Verification of the production of single-stranded RNA (ssRNA) resulting from in vitro transcription. ssRNA was used as the template for the performance of RT-PCR amplification, yielding a correct 220 bp product. (E) Expected result from the sequencing amplicon using LIS-seq. 2.0% (wt/vol) agarose gel displaying a faint PCR smear corresponding to fragments of different lengths harboring the integration site of the provirus in 14 sinpro clones. (F) Expected result from the sequencing amplicon in a pool of infected cells using LIS-seq. 2.0% (wt/vol) agarose gel displaying a faint PCR smear corresponding to fragments of different lengths harboring the integration site of the provirus.
    R3589v, supplied by New England Biolabs, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/r3589v/product/New England Biolabs
    Average 94 stars, based on 1 article reviews
    r3589v - by Bioz Stars, 2026-02
    94/100 stars
    		  Buy from Supplier
    restriction endonuclease mfei hf  (New England Biolabs)
    94
    New England Biolabs restriction endonuclease mfei hf
    Rational design and the experimental validation of the LIS-seq workflow (A) Schematic representation of the experimental strategy of the establishment of single provirus-integrated cellular clones (sinpro clones). A total of 14 clones, in which proviruses demonstrated different transcriptional phenotypes were assigned to four different groups, including the active group (the A group, 4 clones), the attenuated active group (the A-group, 6 clones), the silent group (the S group, 3 clones) and the fluctuation group (the F group, 1 clone) and applied to LIS-seq for the identification of HIV integration sites. (B) Schematic representation of the experimental workflow of LIS-seq. Genomic DNA isolated from sinpro clones was digested with restriction enzymes, HpyCH4III and BplI, followed by in vitro transcription, and RT-PCR amplification with primers embedded with Illumina adaptor sequences. Amplicons are sequenced as 50 bp single reads on a NovaSeq 6000 sequencer (Illumina). (C) Verification of restriction enzyme digestion of genomic DNA isolated from sinpro clones. Genomic DNA is either subjected to BplI plus HpyCH4III (lane 1) or BplI plus HpyCH4III as well <t>as</t> <t>MfeI-HF</t> plus Hpy166I (lane 2). Of note, genomic DNA is digested independently by both pairs of restriction enzymes shown in lane 2. (D) Verification of the production of single-stranded RNA (ssRNA) resulting from in vitro transcription. ssRNA was used as the template for the performance of RT-PCR amplification, yielding a correct 220 bp product. (E) Expected result from the sequencing amplicon using LIS-seq. 2.0% (wt/vol) agarose gel displaying a faint PCR smear corresponding to fragments of different lengths harboring the integration site of the provirus in 14 sinpro clones. (F) Expected result from the sequencing amplicon in a pool of infected cells using LIS-seq. 2.0% (wt/vol) agarose gel displaying a faint PCR smear corresponding to fragments of different lengths harboring the integration site of the provirus.
    Restriction Endonuclease Mfei Hf, supplied by New England Biolabs, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/restriction endonuclease mfei hf/product/New England Biolabs
    Average 94 stars, based on 1 article reviews
    restriction endonuclease mfei hf - by Bioz Stars, 2026-02
    94/100 stars
    		  Buy from Supplier

    Image Search Results


    Rational design and the experimental validation of the LIS-seq workflow (A) Schematic representation of the experimental strategy of the establishment of single provirus-integrated cellular clones (sinpro clones). A total of 14 clones, in which proviruses demonstrated different transcriptional phenotypes were assigned to four different groups, including the active group (the A group, 4 clones), the attenuated active group (the A-group, 6 clones), the silent group (the S group, 3 clones) and the fluctuation group (the F group, 1 clone) and applied to LIS-seq for the identification of HIV integration sites. (B) Schematic representation of the experimental workflow of LIS-seq. Genomic DNA isolated from sinpro clones was digested with restriction enzymes, HpyCH4III and BplI, followed by in vitro transcription, and RT-PCR amplification with primers embedded with Illumina adaptor sequences. Amplicons are sequenced as 50 bp single reads on a NovaSeq 6000 sequencer (Illumina). (C) Verification of restriction enzyme digestion of genomic DNA isolated from sinpro clones. Genomic DNA is either subjected to BplI plus HpyCH4III (lane 1) or BplI plus HpyCH4III as well as MfeI-HF plus Hpy166I (lane 2). Of note, genomic DNA is digested independently by both pairs of restriction enzymes shown in lane 2. (D) Verification of the production of single-stranded RNA (ssRNA) resulting from in vitro transcription. ssRNA was used as the template for the performance of RT-PCR amplification, yielding a correct 220 bp product. (E) Expected result from the sequencing amplicon using LIS-seq. 2.0% (wt/vol) agarose gel displaying a faint PCR smear corresponding to fragments of different lengths harboring the integration site of the provirus in 14 sinpro clones. (F) Expected result from the sequencing amplicon in a pool of infected cells using LIS-seq. 2.0% (wt/vol) agarose gel displaying a faint PCR smear corresponding to fragments of different lengths harboring the integration site of the provirus.

    Journal: STAR Protocols

    Article Title: An in vitro transcription-based protocol for mapping HIV integration sites using lentiviral integration site sequencing

    doi: 10.1016/j.xpro.2025.104284

    Figure Lengend Snippet: Rational design and the experimental validation of the LIS-seq workflow (A) Schematic representation of the experimental strategy of the establishment of single provirus-integrated cellular clones (sinpro clones). A total of 14 clones, in which proviruses demonstrated different transcriptional phenotypes were assigned to four different groups, including the active group (the A group, 4 clones), the attenuated active group (the A-group, 6 clones), the silent group (the S group, 3 clones) and the fluctuation group (the F group, 1 clone) and applied to LIS-seq for the identification of HIV integration sites. (B) Schematic representation of the experimental workflow of LIS-seq. Genomic DNA isolated from sinpro clones was digested with restriction enzymes, HpyCH4III and BplI, followed by in vitro transcription, and RT-PCR amplification with primers embedded with Illumina adaptor sequences. Amplicons are sequenced as 50 bp single reads on a NovaSeq 6000 sequencer (Illumina). (C) Verification of restriction enzyme digestion of genomic DNA isolated from sinpro clones. Genomic DNA is either subjected to BplI plus HpyCH4III (lane 1) or BplI plus HpyCH4III as well as MfeI-HF plus Hpy166I (lane 2). Of note, genomic DNA is digested independently by both pairs of restriction enzymes shown in lane 2. (D) Verification of the production of single-stranded RNA (ssRNA) resulting from in vitro transcription. ssRNA was used as the template for the performance of RT-PCR amplification, yielding a correct 220 bp product. (E) Expected result from the sequencing amplicon using LIS-seq. 2.0% (wt/vol) agarose gel displaying a faint PCR smear corresponding to fragments of different lengths harboring the integration site of the provirus in 14 sinpro clones. (F) Expected result from the sequencing amplicon in a pool of infected cells using LIS-seq. 2.0% (wt/vol) agarose gel displaying a faint PCR smear corresponding to fragments of different lengths harboring the integration site of the provirus.

    Article Snippet: MfeI-HF , New England Biolabs , R3589S.

    Techniques: Biomarker Discovery, Clone Assay, Isolation, In Vitro, Reverse Transcription Polymerase Chain Reaction, Amplification, Sequencing, Agarose Gel Electrophoresis, Infection